Matt Duffy

Evaluator
DISC Type : sdc

Chief Business Officer, Co-CEO at NRx Pharmaceuticals, HOPE Therapeutics, Inc.

United States

Overview

Matt Duffy is a Managing Partner at Lucius Partners and BDR Research, specializing in biotechnology, pharmaceuticals, and medical cannabinoids. His expertise covers strategic planning, product launches, corporate finance, and investor relations. He holds an AB from Duke University and Series 7, 63, and 65 financial licenses.

There is no publicly available information regarding Matts personal life or hobbies. He is, however, an alumnus of Duke University.

He holds Series 7, 63, and 65 licenses, highlighting his deep expertise in both finance and the life sciences sectors.

Personality Overview

Fast But Analytical

Hard To Convince

Quality Focused

They focus on the results, but can still be quite procedural and analytical about how to get there  They have a unique set of diverse traits where they are decisive and methodical but can sometimes be extra cautious and skeptical They are not very likely to become strong advocates of your product or service

Topics They Care About

Biotech Investing
As Managing Partner at Lucius Partners, he is responsible for identifying and funding healthcare and biotechnology companies at various stages of development.
Vaccine Development
Serves as President and Director of Voltron Therapeutics, a company focused on developing a novel Self-Assembling Vaccine technology for oncology and infectious diseases.
Medical Device Innovation
Through Lucius Partners and his board role at AerWave Medical, he is involved with advancing new technologies like ultrasound-based lung denervation systems for COPD and asthma.

Media Appearances

Matt has no verified media appearances

Work History

3-2023 - 12-2025
Chief Business Officer, Co-CEO at NRx Pharmaceuticals, HOPE Therapeutics, Inc.
3-2023 - 7-2024
President, Chief Financial Officer, Director at PD Theranostics, Inc.
11-2020
Member, Board Of Directors at AerWave Medical, Inc
4-2020 - 8-2024
President, Director at PD Theranostics, Inc.
5-2019
President, Director at Voltron Therapeutics, Inc. & HaloVax, LLC

Education

1980 - 1984
AB from Duke University

More Information

Social Presence :

Prographics :

Exp : 37 Location : United States Job Level : Mid-senior Designation : Chief Business Officer, Co-CEO at NRx Pharmaceuticals, HOPE Therapeutics, Inc.
URL has been copied!

Insights For Selling To Matt

During A Call Or A Meeting

DO's

  • Use phrases like ‘the ROI of this’, ‘X% more’ etc.
  • Help them see both - the ‘big picture’ impact and the ROI of the investment
  • Help them weigh the risks by sharing objective proof points instead of anecdotes and examples

DONT's

  • Avoid making strong statements, instead invite them to agree with you by asking them questions
  • Avoid self-deprecating references or general informality, it could decrease their trust in you
  • Avoid inviting them for any social interactions until you have built some rapport with them

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Matt is

  • ROI matters the most to them, followed by process and finally proof of results
  • Will you ever get a clear answer from Matt

  • They might hesitate a little, but will go ahead and say no when necessary (or asked)

Insights For Deal Planning

    How fast (or slow) will Matt move?

  • They are unlikely to move very fast, especially when it comes to new products or services
  • Can Matt take some risk or not?

  • They have relatively low risk-appetite and are not very likely to go for something unproven and risky

You And Matt

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.